Claudio Gasperini - Concepedia

Author

Claudio Gasperini

Also Known As

Antongiulio Gallina, Antonio Gallo, C Gasperini, C. GASPERINI, C. Gasperini, Carlo Pozzilli, Christian Enzinger, Claudio Gasperini, De Bardi, M, Domenico Caputo

429

Publications

15.8K

Citations

H-Index

152

Concepts

All Affiliations

Sapienza University of Rome Carlo Forlanini Hospital University College London Istituti di Ricovero e Cura a Carattere Scientifico Vita-Salute San Raffaele University

About

Claudio Gasperini is an author at Sapienza University of Rome specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	73	3.5K
2	Health Sciences	11	12	329
3	Public Health	10	10	420
4	Nursing	3	3	115
5	Engineering	2	2	27

Claudio Gasperini

185

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis Alena Novotná, Jan Mareš, S. Ratcliffe, European Journal of Neurology	2011	450
Deep gray matter volume loss drives disability worsening in multiple sclerosis Arman Eshaghi, Ferrán Prados, Wallace Brownlee, Annals of Neurology	2018	419
Progression of regional grey matter atrophy in multiple sclerosis Arman Eshaghi, Razvan Marinescu, Alexandra L. Young, Brain	2018	364
The prevalence of pain in multiple sclerosis Claudio Solaro, Giampaolo Brichetto, Maria Pia Amato, Neurology	2004	282
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome Enrico Millefiorini, Claudio Gasperini, Carlo Pozzilli, Journal of Neurology Relapsing-remitting Multiple SclerosisNeurological DisorderMedicineClinical NeurologyClinical Trials	1997	271
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion Massimo Filippi, Maria Pia Amato, Diego Centonze, Journal of Neurology	2022	170
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis Daniela F. Angelini, Barbara Serafini, Eleonora Piras, PLoS Pathogens Autoimmune DiseaseEpstein-barr VirusMedicineImmunologyImmunodominance	2013	167
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS Giovanni Ristori, Silvia Romano, Stefania Cannoni, Neurology	2013	153
‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence Carlo Pozzilli, Valentina Tomassini, Fabiana Marinelli, European Journal of Neurology	2003	151
Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm James H. Cole, Joel Raffel, Tim Friede, Annals of Neurology	2020	145

Page 1